CCL2 and metabolic syndrome: In particular, MCP-1 has been described as the main responsible for the recruitment of monocytes in the inflammatory response, as well as a potential intervention point for the treatment of various diseases associated to MetS and inflammation, including insulin resistance, atherosclerosis and rheumatoid arthritis [59,60].